About Astraeus Technologies
Astraeus Technologies is a company based in Boston (United States) founded in 2015. It operates as a B2B. Astraeus Technologies operates in a competitive market with competitors including Owlstone Medical, Oncimmune, Biodesix, Broncus and OncoCyte, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$100 K (USD), Grant
May 11, 2016
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Astraeus Technologies
Investors in Astraeus Technologies
Astraeus Technologies has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include MIT $100K.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated via MIT-backed program in Cambridge.
|
Locked | Locked | Locked |
Investor details for Astraeus Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Astraeus Technologies
Investment portfolio details for Astraeus Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Astraeus Technologies
Detailed financials for Astraeus Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Astraeus Technologies Comparisons
Peer comparison for Astraeus Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Astraeus Technologies
Astraeus Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owlstone Medical, Oncimmune, Biodesix, Broncus and OncoCyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Non-invasive breath-based diagnostics for cancer and infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Diagnostics and risk assessment solutions for lung cancer are developed.
|
|
| Locked | Locked | Locked |
Cancer detection diagnostics assays are developed and offered.
|
|
| Locked | Locked | Locked |
Minimally invasive technologies for lung disease treatment are developed.
|
|
| Locked | Locked | Locked |
Non-invasive diagnostic test solutions for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Software tools are developed for early lung disease detection.
|
Detailed competitors of Astraeus Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Astraeus Technologies
Complete news archive for Astraeus Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Astraeus Technologies
Astraeus Technologies was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Astraeus Technologies is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Astraeus Technologies, established in 2015 and currently in Dissolved stage, focuses on providing healthcare solutions, medical diagnostics, point-of-care testing, and cancer detection. Delivers breath-based point-of-care diagnostics for early cancer detection solutions. Adapting to market demands with innovation and client-focused strategies.
Astraeus Technologies's top competitors include Biodesix, Owlstone Medical and OncoCyte.
Astraeus Technologies has 1 investor. Key investors include MIT $100K.